Case Reports in Oncological Medicine

Case Reports in Oncological Medicine / 2013 / Article

Case Report | Open Access

Volume 2013 |Article ID 692754 |

Amar M. Eltweri, Gianpiero Gravante, Sarah Louise Read-Jones, Sonpreet Rai, David J. Bowrey, Ian Gordon Haynes, "A Case of Recurrent Mesocolon Myxoid Liposarcoma and Review of the Literature", Case Reports in Oncological Medicine, vol. 2013, Article ID 692754, 6 pages, 2013.

A Case of Recurrent Mesocolon Myxoid Liposarcoma and Review of the Literature

Academic Editor: J. I. Mayordomo
Received02 Aug 2013
Accepted16 Sep 2013
Published07 Nov 2013


Background. Liposarcoma is the second most common soft tissue sarcoma affecting predominantly the retroperitoneal space and extremities. Mesenteric liposarcoma is uncommon and occurs in the small bowel mesentery. In this paper we report the case of a recurrent mesocolon myxoid liposarcoma manifesting 6 years from the initial right hemicolectomy for the primary tumour. Case Report. A 41-year-old female presented with a 4-day history of signs and symptoms indicative of small bowel obstruction, subsequently confirmed on plain abdominal X-ray. In 2006 she underwent a right hemicolectomy for a myxoid liposarcoma of the mesentery. The patient was initially managed conservatively; however she showed no signs of improvement and was taken to theatre for an exploratory laparotomy and division of adhesional bands. During this procedure an incidental finding of a dark purple, smooth pelvic mass was identified with similar macroscopic appearance to that of splenic tissue. Histological examination revealed a recurrent mesocolon myxoid liposarcoma. Conclusion. Mesocolon myxoid liposarcoma is a rare soft tissue neoplastic pathology and carries a high risk of recurrence. Therefore, a symptomatic patient with a previous history of primary liposarcoma excision should be treated with a high index of suspicion and a longer period of followup should be considered.

1. Introduction

Liposarcoma is a group of malignancies of mesenchymal origin that arise from adipose tissue. The incidence peaks in the fourth to sixth decades of life [1]. CT and MRI are important imaging modalities in determining tissue characteristics, the size of the tumour, and invasion into surrounding structures [2]. When feasible, the main treatment is surgical resection followed by adjuvant chemotherapy and/or radiotherapy [3]. Important prognostic factors include the histological classification and tumour site and size [4] while positive surgical margins are key predictors for local recurrence [3].

Liposarcomas are usually located in the lower limbs of adults [1, 4], rarely in the small bowel mesentery and even less frequently in the mesocolon. In this report, we present the case of a recurrent mesocolon myxoid liposarcoma manifesting six years from the initial right hemicolectomy and review the literature regarding mesenteric liposarcomas.

2. Case Report

A 41-year-old female presented to the emergency department with a four-day history of signs and symptoms indicative of abdominal obstruction. Her past medical history included hypothyroidism due to autoimmune thyroiditis, managed with levothyroxine. In 2006 she underwent a right hemicolectomy for a myxoid liposarcoma grade 1-2 infiltrating the small and large bowels. The specimen weighed almost 3 kilograms with dimensions  cm. The removal was radical with free margins and an intact tumour capsule. Postoperatively, no adjuvant therapy was indicated and close followup was recommended.

During the current admission she was dehydrated, haemodynamically stable, and apyrexial. Abdominal examination revealed a distended abdomen, tympanic to percussion, with no signs of peritonism or abdominal wall hernias. Blood investigations showed a raised urea (8.7 mmol/L) and WCC . Abdominal X-ray revealed grossly dilated small bowel loops. The initial treatment was conservative with nil by mouth, intravenous fluid resuscitation, nasogastric tube, and urinary catheter for fluid balance. After twenty-four hours the patient showed no signs of improvement and underwent an exploratory laparotomy. An adhesional band was found to be the cause of the small bowel obstruction and was divided. The entire small bowel was viable and no evidence of intra-abdominal or peritoneal metastasis was identified. However, a dark purple, smooth pelvic mass was found attached to the pelvic wall by a small stalk with similar macroscopic appearance to that of splenic tissue (Figure 1). The mass was carefully detached off the pelvic wall and sent for final histological analysis.

After the laparotomy the patient had an uncomplicated recovery and was discharged home on the eighth postoperative day. Histology confirmed a recurrence of the previous myxoid liposarcoma (Figure 2). One month later a CT scan of the chest, abdomen, and pelvis showed a new well-defined oval hypodense mass in the right iliac fossa adjacent to the anastomotic surgical sutures site that was suspicious for recurrence (Figure 3). In light of these findings, the patient has been referred to the regional sarcoma centre for further management.

3. Discussion

According to the World Health Organisation classification of tumours [5], liposarcomas are divided into well-differentiated/dedifferentiated, pleomorphic, myxoid/round cell, and mixed type liposarcoma (Table 1). Myxoid liposarcoma is a mesenchymal malignant tumour composed of uniform round to oval primitive nonlipogenic mesenchymal cells and a number of small signet-ring lipoblasts in a myxoid stroma with a characteristic branching vascular pattern. It is also called round cell liposarcoma and it is the second most common liposarcoma subtype. It usually presents during the fourth and fifth decades of life as a large painless mass in the deep soft tissue of the extremities. More than two-thirds of the myxoid liposarcoma cases occur within the muscles of the thigh and rarely occur in the subcutaneous tissues or the retroperitoneum. The presence of necrosis usually indicates a poor prognosis [5]. Myxoid liposarcoma is likely to recur locally and one-third of cases develop distant metastasis [5]. The sites of reported metastasis and/or recurrence of liposarcoma were local, cardiac, hepatic, mesenteric, bone, and pulmonary [3, 6, 7]. The overall survival ranges between 6 and 20 years [8].

TypeIncidenceRecurrencePrognostic factorMortality rateSurvival

Atypical lipomatous tumor “ALT”/well differentiated “WD”40–45%Lesions located in a surgically amenable soft tissue do not recur following WLE with clear marginAnatomic locations “deep soft tissue liposarcoma carries high risk”0% for ALT of extremities to 80% for WD in the retroperitoneum6–11 years when followed up for 10–20 years
Dedifferentiated 10%40% local recurrence and 15–20% for distant metastasisAnatomic locations (retroperitoneum carries the worst clinical behaviour)28–30% at 5-year followup (this figure is higher at 10–20-year followup)
Myxoid 10%Prone to recur locally and one-third develop metastasisHigh histological grade (≥5% RC areas), presence of necrosis, and TP53 overexpression carries unfavourable prognosis
Pleomorphic 5%30–50% metastasis rateTumour depth, size, >20 mitosis in 10 HPFs, and presence of necrosis carries a worse prognosis40–50% mortalityPatient dies within a short period of time
Mixed type Extremely rare

Through literature review, only five mesenteric liposarcomas of the mesocolon have been published to date [3, 911]. Among them only one was recurrent [12]; therefore our case represents the second recurrence of a myxoid liposarcoma arising from the mesocolon reported in the literature. Benedict first described mesenteric liposarcomas in 1946 as a recurrent liposarcoma of the transverse mesocolon. Since then, various cases have been presented (Table 2). Mesenteric liposarcomas affect both the male and female sex equally and are more evident during the fifth to seventh decade of life. It may present in any age group and has been reported in patients as young as 15 years old [13]. The clinical presentation varies and includes abdominal pain, distension, palpable mass, constipation, vomiting, and weight loss (Table 2). CT and MRI investigations add important data for the differential diagnosis and each histological type has different radiological characteristics [2, 14]. The mesenteric liposarcomas have CT attenuation less than that of muscle and MRI signal intensity similar to that of water. Before contrast enhancement, the myxoid components appeared to be cystic on CT attenuation and MRI signal intensity and they appeared to be solid after contrast enhancement [14]. In our case the CT scan appearance was a well-defined oval hypodense uniform mass with a central rounded higher density soft tissue area within it.

Size (cm)Weight (kg)TypeFollowupRecurrence

Ishiguro et al. [3]30 y/MAbdominal distensionTerminal ileum mesentery and right sided mesocolonPrimary30 cmMyxoid26 mYes (abdominal)
Nakamura et al. [16]77 y/FFeverIleocecal mesenteryPrimary10.5 × 7 × 7 cmPleomorphic7 mNo
Cha [17]76 y/FAbdominal mass and frequent micturitionSmall bowel mesenteryPrimary5 × 4.3 × 4.2 cmWell differentiated
Jukic et al. [4]77 y/MWeight loss, oedema, and shortness of breathSmall bowel mesenteryPrimary
35 × 15 × 15 cm23.5 kgWell diff./dediff. and pleomorphic8 daysRIP
Zhianpour and Sirous [9]35 y/MConstipation, weight loss, vomiting, and abdominal distensionSigmoid mesocolonPrimary50 × 40 × 10 cmWell differentiated24 mNo
Benedict [12]56 y/FConstipation, belching, and feeling bloatedTransverse mesocolonRecurrent12.5 cm (5 in)Low-grade liposarcoma11 mNo
Núñez Fernández et al. [18]67 y/FAbdominal massJejunal mesenteryPrimary8.5 × 7.5 cmMyxoid12 mNo
Tomita et al. [6]47 y/FAbdominal distension, frequent urination, and constipationIleal mesenteryMetastatic28 × 23 × 22 cm1.8 kgMyxoid7 mYes (liver and heart)
Pawel et al. [13]15 y/FVomiting and abdominal painSmall bowel mesenteryPrimaryLarge “unresectable”PleomorphicUnresectable tumour
Nagawa et al. [7]33 y/MVomiting and abdominal painIleal mesentery and omentumMetastatic8 × 5 × 5 cm “mesenteric” and 13 × 11 × 5 cm “omental”Round cell1.3 mRIP
Lung, liver, and bone mets
Cerullo et al. [19]55 y/MAbdominal distension and weight lossMesenteryPrimary40 cm9 kgWell differentiated12 mNo
Yuri et al. [1]73 y/MAbdominal massDuodenal mesenteryPrimary12.4 × 9.6 cm0.5 kgWell differentiated6 mNo
Hirakoba et al. [14]65 y/FAbdominal massJejunal mesenteryPrimary16 × 13 × 9 cm0.7 kgWell differentiated
Jain et al. [15]50 y/MAbdominal mass, fever, and weight lossJejunal mesenteryPrimary20 × 20 cm1.8 kgPleomorphic
Goel et al. [10]48 y/MAbdominal pain and nauseaSigmoid mesocolon and mesorectumPrimaryWell differentiated
Panagiotopoulos et al. [20]71 y/MAbdominal pain and distensionSmall bowel mesenteryRecurrent10 × 9 × 7 cmDedifferentiatedIncomplete resection
Amato et al. [11]75 y/FConstipationSigmoid mesocolonPrimary2 cmWell differentiated24 mNo
Calò et al. [21]43 y/MAbdominal pain, change in bowel habit, constipation, dyspeptic syndrome, and meteorismSmall bowel mesenteryPrimary20 × 16 cm2.1 kgWell differentiated33 mNo
Manson [22]60 y/FVomiting, abdominal pain, weight loss, and distensionSmall bowel mesentery “ileum”PrimaryWell differentiated1 mNo
Current case41 y/FAbdominal pain, distension, and vomitingMesocolonRecurrent12 × 11 × 6 cm0.3 kgMyxoid2 mYes (current episode)

The only curative treatment for a mesenteric liposarcoma consists of a wide excision and clear surgical margins followed by adjuvant radiotherapy in high risk patients [15]. It is reported that neoadjuvant chemotherapy helps in reducing the size of the primary tumour and renders the tumour resectable without the need for en bloc resection of the adjacent organs. However, the role of adjuvant chemotherapy remains unclear [3].

4. Take Home Messages

(1)Patients with previous history of liposarcoma should be treated with high index of suspicion, even after five years of disease-free followup.(2)CT scan is an ideal investigation to detect any evidence of disease recurrence as well as to identify the possible cause of small bowel obstruction.(3)Followup of these patients in regional sarcoma centres is ideal and research to investigate the role of adjuvant chemotherapy is required.

5. Conclusions

Mesenteric liposarcoma is a rare soft tissue malignancy with high risk of metastasis and recurrence. We are adding to the literature the second case of a recurrent mesocolon liposarcoma 6 years after complete excision of the liposarcoma lesion.

Conflict of Interests

All authors declare no conflict of interests and this case report did not require any funding support.

Authors’ Contribution

All authors have contributed in the paper concept, reviewing the initial and final drafts. Dr. Sarah Louise Reed-Jones provided the histopathology slide images.


  1. T. Yuri, T. Miyaso, H. Kitade et al., “Well-differentiated liposarcoma, an atypical lipomatous tumor, of the mesentery: a case report and review of the literature,” Case Reports in Oncology, vol. 4, no. 1, pp. 178–185, 2011. View at: Publisher Site | Google Scholar
  2. T. Kim, T. Murakami, H. Oi et al., “CT and MR imaging of abdominal liposarcoma,” The American Journal of Roentgenology, vol. 166, no. 4, pp. 829–833, 1996. View at: Google Scholar
  3. S. Ishiguro, S. Yamamoto, H. Chuman, and Y. Moriya, “A case of resected huge ileocolonic mesenteric liposarcoma which responded to pre-operative chemotherapy using doxorubicin, cisplatin and ifosfamide,” Japanese Journal of Clinical Oncology, vol. 36, no. 11, pp. 735–738, 2006. View at: Publisher Site | Google Scholar
  4. Z. Jukic, I. Brcic, M. Zovak, M. Vucic, A. Mijic, and B. Kruslin, “Giant mixed-type liposarcoma of the mesentery: case report,” Acta Clinica Croatica, vol. 51, no. 1, pp. 97–101, 2012. View at: Google Scholar
  5. C. D. M. Fletcher, K. K. Unni, and F. Mertens, Eds., World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, IARC Press International Agency for Research on Cancer, Lyon, France, 2002.
  6. H. Tomita, K. Yamaguchi, M. Matsuo, T. Ohno, Y. Nishimoto, and Y. Hirose, “Metastatic myxoid liposarcoma in the mesentery: what is debated? Case report and a review of the literature,” The American Surgeon, vol. 72, no. 1, pp. 68–70, 2006. View at: Google Scholar
  7. H. Nagawa, N. Tsuno, H. Saito, and T. Muto, “Ileal obstruction due to metastatic liposarcoma: a case report,” Gastroenterologia Japonica, vol. 28, no. 5, pp. 706–711, 1993. View at: Google Scholar
  8. T. Hasegawa, K. Seki, F. Hasegawa et al., “Dedifferentiated liposarcoma of retroperitoneum and mesentery: varied growth patterns and histological grades—a clinicopathologic study of 32 cases,” Human Pathology, vol. 31, no. 6, pp. 717–727, 2000. View at: Google Scholar
  9. M. Zhianpour and M. Sirous, “Abdominal imaging huge liposarcoma of the sigmoid mesocolon: a case report,” Iranian Journal of Radiology, vol. 7, no. 4, pp. 251–253, 2010. View at: Google Scholar
  10. A. K. Goel, S. Sinha, A. Kumar, A. K. Karak, and T. K. Chattopadhyay, “Liposarcoma of the mesocolon—case report of a rare lesion,” Surgery Today, vol. 24, no. 11, pp. 1003–1006, 1994. View at: Publisher Site | Google Scholar
  11. G. Amato, A. Martella, F. Ferraraccio et al., “Well differentiated “lipoma-like” liposarcoma of the sigmoid mesocolon and multiple lipomatosis of the rectosigmoid colon. Report of a case,” Hepatogastroenterology, vol. 45, no. 24, pp. 2151–2156, 1998. View at: Google Scholar
  12. R. B. Benedict, “Liposarcoma of the mesentery,” Annals of Surgery, vol. 124, no. 3, pp. 519–523, 1946. View at: Google Scholar
  13. B. R. Pawel, J. P. de Chadarévian, S. Inniss, P. Kalwinski, S. R. Paul, and W. H. Weintraub, “Mesenteric pleomorphic liposarcoma in an adolescent,” Archives of Pathology and Laboratory Medicine, vol. 121, no. 2, pp. 173–176, 1997. View at: Google Scholar
  14. M. Hirakoba, K. Kume, M. Yamasaki, K. Kanda, I. Yoshikawa, and M. Otsuki, “Primary mesenteric liposarcoma successfully diagnosed by preoperative imaging studies,” Internal Medicine, vol. 46, no. 7, pp. 373–375, 2007. View at: Publisher Site | Google Scholar
  15. S. K. Jain, A. Mitra, R. C. Kaza, and S. Malagi, “Primary mesenteric liposarcoma: an unusual presentation of a rare condition,” Journal of Gastrointestinal Oncology, vol. 3, no. 2, pp. 147–150, 2012. View at: Google Scholar
  16. A. Nakamura, S. Tanaka, H. Takayama et al., “A mesenteric liposarcoma with production of granulocyte colony-stimulating factor,” Internal Medicine, vol. 37, no. 10, pp. 884–890, 1998. View at: Google Scholar
  17. E. J. Cha, “Dedifferentiated liposarcoma of the small bowel mesentery presenting as a submucosal mass,” World Journal of Gastrointestinal Oncology, vol. 3, no. 7, pp. 116–118, 2011. View at: Google Scholar
  18. M. J. Núñez Fernández, A. García Blanco, A. López Rodríguez et al., “Primary mesenteric liposarcoma of jejunum: presentation like a cystic mass,” Minerva Medica, vol. 96, no. 6, pp. 425–428, 2005. View at: Google Scholar
  19. G. Cerullo, D. Marrelli, B. Rampone, E. Perrotta, S. Caruso, and F. Roviello, “Giant liposarcoma of the mesentery. Report of a case,” Annali Italiani di Chirurgia, vol. 78, no. 5, pp. 443–445, 2007. View at: Google Scholar
  20. N. Panagiotopoulos, C. Kyriakides, R. A. Weerakkody et al., “Recurrent dedifferentiated liposarcoma arising from the small bowel mesentery: a case report,” Journal of Gastrointestinal Cancer, vol. 43, no. 1, supplement, pp. 175–177, 2012. View at: Publisher Site | Google Scholar
  21. P. G. Calò, S. Farris, A. Tatti, M. Tuveri, G. Catani, and A. Nicolosi, “Primary mesenteric liposarcoma. Report of a case,” Il Giornale di Chirurgia, vol. 28, no. 8-9, pp. 318–320, 2007. View at: Google Scholar
  22. J. M. Manson, “Mesenteric liposarcoma, a rare cause of intestinal obstruction,” British Journal of Surgery, vol. 38, no. 151, pp. 394–396, 1951. View at: Google Scholar

Copyright © 2013 Amar M. Eltweri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.